References
- Burger JA, Montserrat E. Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling. Blood 2013;121:1501–1509.
- Filip AA, Cisel B, Koczkodaj D, et al. Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?. Blood Cells Mol Dis 2013;50:263–270.
- Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 2013;369: 32–42.
- Fecteau JF, Bharati IS, O’Hayre M, et al. Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). Mol Med 2012;18:19–28.
- Huber S, Oelsner M, Decker T, et al. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1. Leukemia 2011;25:838–847.
- Malik A, Shoukier M, Garcia-Manero G, et al. Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study. Clin Lymphoma Myeloma Leuk 2013;13:292–295.
- Rawstron AC. Occult B-cell lymphoproliferative disorders. Histopathology 2011;58:81–89.
- Robak T, Urbanska-Rys H, Smolewski P, et al. Chronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2003;44:2001–2008.
- Mazumdar R, Evans P, Culpin R, et al. The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy. Leuk Res 2013;37: 614–618.
- Seiffert M, Schulz A, Ohl S, et al. Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood 2010;116:4223–4230.